
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Business practices</dc:title>
  <dc:title>Health Policy Tracking Service issue brief</dc:title>
  <dc:creator>Steiner, David J., author.</dc:creator>
  <dc:subject>Crime -- legislation &amp; jurisprudence</dc:subject>
  <dc:subject>Drug Industry -- legislation &amp; jurisprudence</dc:subject>
  <dc:subject>Health Care Sector -- legislation &amp; jurisprudence</dc:subject>
  <dc:subject>Opioid Epidemic</dc:subject>
  <dc:description>This issue brief discusses federal and state legislative action from 2022 dealing with pharmaceutical companies. Criminal cases and settlements in the states are mentioned as well as cases dealing with opioids.</dc:description>
  <dc:publisher>[Toronto, Ontario] : Thomson Reuters, 19-December-2022</dc:publisher>
  <dc:contributor>Thomson Reuters, issuing body.</dc:contributor>
  <dc:type>Technical Report</dc:type>
  <dc:format>Text</dc:format>
  <dc:format>1 online resource (1 PDF file (24 pages)).</dc:format>
  <dc:identifier>nlm:nlmuid-9918645959406676-pdf</dc:identifier>
  <dc:identifier>9918645959406676</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/9918645959406676</dc:identifier>
  <dc:language>English</dc:language>
  <dc:coverage>United States</dc:coverage>
  <dc:rights>Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. http://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>